MicroRNAs of Toxocara canis and their predicted functional roles

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Ma, Guangxu ^a,b   Luo, Yongfang ^a   Zhu, Honghong ^a   Luo, Yongli ^a   Korhonen, Pasi K ^b   Young, Neil D ^b   Gasser, Robin B ^b   Zhou, Rongqiong ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Drug resistance; Host parasite interactions; microRNAs (miRNAs); Reproduction and development; Toxocara canis

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 100D; MICRORNA 103A; MICRORNA 103B; MICRORNA 125A 5P; MICRORNA 2305; MICRORNA 265; MICRORNA 2861; MICRORNA 2881; MICRORNA 34; MICRORNA 3610; MICRORNA 3885; MICRORNA 4459; MICRORNA 57 5P; MICRORNA 6090; MICRORNA 71; MICRORNA 753B 3P; MICRORNA 84 5P; MICRORNA 87; MICRORNA 87A; MICRORNA 87B; MICRORNA LET 7 5P; MICRORNA LET 7B 5P; MICRORNA LET 7C 5P; MICRORNA LET 7E 5P; MICRORNA LET 7F 5P; SMALL NUCLEAR RNA; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG; UNINDEXED DRUG; TRANSCRIPTOME;

ADULT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FEMALE; HEMIDESMOSOME; HIGH THROUGHPUT SEQUENCING; HOST PARASITE INTERACTION; LARVAL DEVELOPMENT; MALE; MORPHOGENESIS; NONHUMAN; RNA SEQUENCE; RNA TRANSCRIPTION; SEX DETERMINATION; TOXOCARA CANIS; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SEX DIFFERENCE;

ANIMALS; BASE SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; MALE; MICRORNAS; SEX FACTORS; TOXOCARA CANIS; TRANSCRIPTOME;

EID: 85007605008     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1508-3     Document Type: Article

References (80)

1. Macpherson CN. The epidemiology and public health importance of toxocarosis: A zoonosis of global importance. Int J Parasitol. 2013;43:999-1008.
2. Nijsse R, Ploeger HW, Wagenaar JA, Mughini-Gras L. Toxocara canis in household dogs: Prevalence, risk factors and owners' attitude towards deworming. Parasitol Res. 2015;114:561-9.
3. Mendonça LR, Veiga RV, Dattoli VC, Figueiredo CA, Fiaccone R, Santos J, et al. Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American. PLoS Negl Trop Dis. 2012;6:e1886.
4. Schoenardie ER, Scaini CJ, Brod CS, Pepe MS, Villela MM, McBride AJ, et al. Seroprevalence of Toxocara infection in children from southern Brazil. J Parasitol. 2013;99:537-9.
5. Taira K, Saeed I, Permin A, Kapel CM. Zoonotic risk of Toxocara canis infection through consumption of pig or poultry viscera. Vet Parasitol. 2004;121:115-24.
6. Overgaauw PA, van Zutphen L, Hoek D, Yaya FO, Roelfsema J, Pinelli E, et al. Zoonotic parasites in fecal samples and fur from dogs and cats in the Netherlands. Vet Parasitol. 2009;163:115-22.
7. Smith H, Holland C, Taylor M, Magnaval JF, Schantz P, Maizels R. How common is human toxocarosis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182-8.
8. EI-Tras WF, Holt HR, Tayel AA. Risk of Toxocara canis eggs in stray and domestic dog hair in Egypt. Vet Parasitol. 2011;178:319-23.
9. Despommier D. Toxocarosis: Clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265-72.
10. Caldera F, Burlone ME, Genchi C, Pirisi M, Bartoli E. Toxocara encephalitis presenting with autonomous nervous system involvement. Infection. 2013;41:691-4.
11. Kamuyu G, Bottomley C, Mageto J, Lowe B, Wilkins PP, Noh JC, et al. Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa. PLoS Negl Trop Dis. 2014;8:e2908.
12. Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocarosis in North America: A systematic review. PLoS Negl Trop Dis. 2014;8:e3116.
13. Li L, Gao W, Yang X, Wu D, Bi H, Zhang S, et al. Asthma and toxocarosis. Ann Allergy Asthma Immunol. 2014;113:187-92.
14. Cassenote AJ, Lima AR, Pinto Neto JM, Rubinsky-Elefant G. Seroprevalence and modifiable risk factors for Toxocara spp. in Brazilian schoolchildren. PLoS Negl Trop Dis. 2014;8:e2830.
15. Cong W, Zhang XX, Zhou N, Yu CZ, Chen J, Wang XY, et al. Toxocara seroprevalence among clinically healthy individuals, pregnant women and psychiatric patients and associated risk factors in Shandong Province, Eastern China. PLoS Negl Trop Dis. 2014;8:e3082.
16. Moreira GM, Telmo Pde L, Mendonça M, Moreira AN, McBride AJ, Scaini CJ, et al. Human toxocarosis: Current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014;30:456-64.
17. Chen J, Zhou DH, Nisbet AJ, Xu MJ, Huang SY, Li MW, et al. Advances in molecular identification, taxonomy, genetic variation and diagnosis of Toxocara spp. Infect Genet Evol. 2012;12:1344-8.
18. Holland CV, Smith HV. Toxocara - The Enigmatic Parasite. Wallingford: CABI Publishing; 2006. p. 301.
19. Gasser RB. A perfect time to harness advanced molecular technologies to explore the fundamental biology of Toxocara species. Vet Parasitol. 2013;193:353-64.
20. Zhu XQ, Korhonen PK, Cai H, Young ND, Nejsum P, von Samson-Himmelstjerna G, et al. Genetic blueprint of the zoonotic pathogen Toxocara canis. Nat Commun. 2015;6:6145.
21. Shao C, Xu MJ, Alasaad S, Song HQ, Peng L, Tao JP, Zhu XQ. Comparative analysis of microRNA profiles between adult Ascaris lumbricoides and Ascaris suum. BMC Vet Res. 2014;10:99.
22. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97.
23. Grosshans H, Filipowicz W. Molecular biology: The expanding world of small RNAs. Nature. 2008;51:414-6.
24. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136:215-33.
25. Neeb ZT, Zahler AM. An expanding world of small RNAs. Dev Cell. 2014;28:111-2.
26. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-54.
27. Benfey PN. Molecular biology: MicroRNA is here to stay. Nature. 2003; 425:244-5.
28. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27:5959-74.
29. Lalaouna D, Eyraud A, Chabelskaya S, Felden B, Massé E. Regulatory RNAs involved in bacterial antibiotic resistance. PLoS Pathog. 2014;10:e1004299.
30. Bidarimath M, Khalaj K, Wessels JM, Tayade C. MicroRNAs, immune cells and pregnancy. Cell Mol Immunol. 2014;11:538-47.
31. Winter AD, Weir W, Hunt M, Berriman M, Gilleard JS, Devaney E, et al. Diversity in parasitic nematode genome: The microRNAs of Brugia pahangi and Haemonchus contortus are largely novel. BMC Genomics. 2012;13:4.
32. Ahmed R, Chang Z, Younis AE, Langnick C, Li N, Chen W, et al. Conserved miRNAs are candidate post-transcriptional regulators of developmental arrest in free-living and parasitic nematodes. Genome Biol Evol. 2013;5:1246-60.
33. Cai P, Hou N, Piao X, Liu S, Liu H, Yang F, et al. Profiles of small non-coding RNAs in Schistosoma japonicum during development. PLoS Negl Trop Dis. 2011;5:e1256.
34. Sun J, Wang S, Li C, Ren Y, Wang J. Novel expression profiles of microRNAs suggest that specific miRNAs regulate gene expression for the sexual maturation of female Schistosoma japonicum after pairing. Parasit Vectors. 2014;7:177.
35. Harris JF, Micheva-Viteva S, Li N, Hong-Geller E. Small RNA-mediated regulation of host-pathogen interactions. Virulence. 2013;4:785-95.
36. Buck AH, Coakley G, Simbari F, McSorley HJ, Quintana JF, Le Bihan T, et al. Exosomes secreted by nematode parasites transfer sRNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488.
37. Turner M, Galloway A, Vigorito E. Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol. 2014;15:484-91.
38. Devaney E, Winter AD, Britton C. MicroRNAs: A role in drug resistance in parasitic nematodes? Trends Parasitol. 2010;26:428-33.
39. Jacobs DE, Zhu XQ, Gasser RB, Chilton NB. PCR-based methods for identification of potentially zoonotic ascaridoid parasites of the dog, fox and cat. Acta Trop. 1997;68:191-200.
40. Urquhart GM, Armour J, Duncan JL, Dunn AM, Jennings FW. Veterinary Parasitology. Scotland: Blackwell Science; 2003.
41. http://soap.genomics.org.cn/ (2016). Accessed 13 Jan 2016.
42. http://www.ncbi.nlm.nih.gov/ (2016). Accessed 13 Jan 2016.
43. http://rfam.janelia.org/ (2016). Accessed 13 Jan 2016.
44. http://www.mirbase.org/ (2016). Accessed 13 Jan 2016.
45. http://sourceforge.net/projects/mireap/ (2016). Accessed 13 Jan 2016.
46. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10:1507-17.
47. http://www.geneontology.org (2016). Accessed 13 Jan 2016.
48. http://www.kegg.jp/kegg/pathway.html (2016). Accessed 13 Jan 2016.
49. Tritten L, Burkman E, Moorhead A, Satti M, Geary J, Mackenzie C, et al. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS Negl Trop Dis. 2014;8:e2971.
50. Tritten L, O'Neill M, Nutting C, Wanji S, Njouendoui A, Fombad F, et al. Loa loa and Onchocerca ochengi miRNAs detected in host circulation. Mol Biochem Parasitol. 2014;198:14-7.
51. Zamanian M, Fraser LM, Agbedanu PN, Harischandra H, Moorhead AR, Day TA, et al. Release of small RNA-containing exosome-like vesicles from the human filarial parasite Brugia malayi. PLoS Negl Trop Dis. 2015;9:e0004069.
52. Wang J, Czech B, Crunk A, Wallace A, Mitreva M, Hannon GJ, et al. Deep small RNA sequencing from the nematode Ascaris reveals conservation, functional diversification, and novel developmental profiles. Genome Res. 2011;21:1462-77.
53. http://www.clustal.org/ (2016). Accessed 13 Jan 2016.
54. Benes V, Castoldi M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods. 2010;50:244-9.
55. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699-707.
56. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007;196:261.
57. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, et al. Let-7 expression defines two differentiation stages of cancer. PNAS. 2007;104:11400-5.
58. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8.
59. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14:475-88.
60. Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell. 2013;153:516-9.
61. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901-6.
62. Hoogstrate SW, Volkers RJ, Sterken MG, Kammenga JE, Snoek LB. Nematode endogenous small RNA pathways. Worm. 2014;3:e28234.
63. Sarkies P, Selkirk ME, Jones JT, Blok V, Boothby T, Goldstein B, et al. ancient and novel small rna pathways compensate for the loss of piRNAs in multiple independent nematode lineages. PLoS Biol. 2015;13:e1002061.
64. Dieterich C, Sommer RJ. How to become a parasite - lessons from the genomes of nematodes. Trends Genet. 2009;25:203-9.
65. Theodoropoulos G, Hicks SJ, Corfield AP, Miller BG, Carrington SD. The role of mucins in host-parasite interactions: Part II - helminth parasites. Trends Parasitol. 2001;17:130-5.
66. Hewitson JP, Grainger JR, Maizels RM. Helminth immunoregulation: The role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol. 2009;167:1-11.
67. Maizels RM. Toxocara canis: Molecular basis of immune recognition and evasion. Vet Parasitol. 2013;193:365-74.
68. Zheng Y, Cai X, Bradley JE. MicroRNAs in parasites and parasite infection. RNA Biol. 2013;10:371-9.
69. Twu O, Johnson PJ. Parasite extracellular vesicles: Mediators of intercellular communication. PLoS Pathog. 2014;10:e1004289.
70. Hoy AM, Lundie RJ, Ivens A, Quintana JF, Nausch N, Forster T, et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection. PLoS Negl Trop Dis. 2014;8:e2701.
71. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10:111-22.
72. Manzano-Román R, Siles-Lucas M. MicroRNAs in parasitic diseases: Potential for diagnosis and targeting. Mol Biochem Parasitol. 2012;186:81-6.
73. Marcilla A, Trelis M, Cortés A, Sotillo J, Cantalapiedra F, Minguez MT, et al. Extracellular vesicles from parasitic helminths contain specific excretory/ secretory proteins and are internalized in intestinal host cells. PLoS One. 2012;7:e45974.
74. Britton C, Winter AD, Gillan V, Devaney E. MicroRNAs of parasitic helminths - Identification, characterization and potential as drug targets. Int J Parasitol Drugs Drug Resist. 2014;4:85-94.
75. Prichard RK, Roulet A. ABC transporters and beta tubulin in macrocyclic lactone resistance: Prospects for marker development. Parasitology. 2007; 134:1123-32.
76. Williamson SM, Robertson AP, Brown L, Williams T, Woods DJ, Martin RJ, et al. The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: Formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog. 2009;5:e1000517.
77. Rao VT, Siddiqui SZ, Prichard RK, Forrester SG. A dopamine-gated ion channel (HcGGR3∗) from Haemonchus contortus is expressed in the cervical papillae and is associated with macrocyclic lactone resistance. Mol Biochem Parasitol. 2009;166:54-61.
78. Zhang L, Hammell M, Kudlow BA, Ambros V, Han M. Systematic analysis of dynamic miRNA-target interactions during C. elegans development. Development. 2009;136:3043-55.
79. Leung AK, Sharp PA. MicroRNA functions in stress responses. Mol Cell. 2010;40:205-15.
80. Schmidt MF. Drug target miRNAs: Chances and challenges. Trends Biotechnol. 2014;32:578-85.